3 learning resources available for this topic
Breast disease encompasses a wide spectrum of benign and malignant conditions affecting breast tissue, ranging from common fibrocystic changes to invasive carcinomas. These conditions can present with various symptoms including palpable masses, breast pain, nipple discharge, or skin changes, requiring systematic evaluation through clinical examination, imaging, and often tissue sampling.
Breast diseases arise from disruptions in normal mammary gland development, hormonal regulation, or cellular growth control mechanisms. Benign conditions like fibrocystic disease result from hormonal fluctuations affecting ductal and stromal tissue, while malignant transformations involve genetic mutations leading to uncontrolled cellular proliferation, invasion, and potential metastasis through lymphatic and hematogenous spread.
Effective breast disease management requires systematic approach using the triple assessment: clinical examination, imaging (mammography, ultrasound, or MRI), and tissue sampling when indicated. Risk stratification considers patient age, family history, genetic factors, and imaging characteristics to determine appropriate surveillance intervals and treatment strategies, with multidisciplinary coordination essential for optimal outcomes in both benign and malignant conditions.